4//SEC Filing
INGENITO GARY 4
Accession 0001161697-25-000069
CIK 0001369568other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 5:00 PM ET
Size
9.2 KB
Accession
0001161697-25-000069
Insider Transaction Report
Form 4
INGENITO GARY
Chief Med. & Reg. Officer
Transactions
- Exercise/Conversion
Common Stock, par value $0.001 per share
2025-02-14+10,000→ 71,308 total - Tax Payment
Common Stock, par value $0.001 per share
2025-02-14−2,435→ 68,873 total - Exercise/Conversion
Restricted Stock Units
2025-02-14−10,000→ 1,015,282 total→ Common Stock (10,000 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
- [F2]Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted stock units.
- [F3]Derivative securities vested in equal tranches, 1/3rd on February 14, 2023, 1/3rd on February 14, 2024 and 1/3rd on February 14, 2025.
- [F4]Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The final tranche of shares was delivered on February 14, 2025.
Documents
Issuer
CATALYST PHARMACEUTICALS, INC.
CIK 0001369568
Entity typeother
Related Parties
1- filerCIK 0001279473
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 5:00 PM ET
- Size
- 9.2 KB